SNDX Syndax Pharmaceuticals Inc
2,138
$20.08
0.99%
| Watchers | 2,138 |
| 52-Wk Low | $11.22 |
| 52-Wk High | $25.34 |
| Market Cap | $1.72B |
| Volume | 997,728.00 |
| 52-Wk High | $25.34 |
| 52-Wk Low | $11.22 |
Syndax Pharmaceuticals Appoints Aleksandra Rizo, M.D., Ph.D. to the Board of DirectorsPR Newswire • 13 days ago
Syndax Pharmaceuticals Appoints Aleksandra Rizo, M.D., Ph.D. to the Board of Directors Syndax Pharmaceuticals Appoints Aleksandra Rizo, M.D., Ph.D. to the Board of Directors PR Newswire WALTHAM...
Share to Feed
Syndax Announces Participation at the Bank of America Securities 2024 Health Care Conference Syndax Announces Participation at the Bank of America Securities 2024 Health Care Conference PR Newswire...
Syndax Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Clinical and Business Update Syndax Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Clinical...
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire WALTHAM, Mass...
Syndax to Announce First Quarter 2024 Financial Results and Host Conference Call and Webcast on May 8, 2024 Syndax to Announce First Quarter 2024 Financial Results and Host Conference Call and...
Syndax Announces Participation at the Stifel 2024 Virtual Targeted Oncology Forum Syndax Announces Participation at the Stifel 2024 Virtual Targeted Oncology Forum PR Newswire WALTHAM, Mass., April...
Syndax Presents Positive Pediatric Data from Pivotal AUGMENT-101 Trial of Revumenib in Relapsed/Refractory KMT2Ar Acute Leukemia at ASPHO Plenary Session Syndax Presents Positive Pediatric Data from...
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire WALTHAM, Mass...
This is a Bullish indicator signaling SNDX's price could rise from here. Traders may explore going long the stock or buying call options...
This is a signal that SNDX's price trend could be reversing, and it may be an opportunity to sell the stock or take a defensive position...